Tuesday, January 11, 2022

< + > Medicare Seeks To Limit Coverage For Controversial Alzheimer’s Drug Aduhelm

Doctors demanded the FDA revoke its approval for the Alzheimer’s drug Aduhelm, which can cause side effects like brain bleeding.

at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

< + > Third Way Health Raises $15M | Salma Health Launches Integrated Brain Health Center of Excellence

Check out today’s featured companies who have recently raised a round of funding, and be sure to check out the full list of past healthcare ...